|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Rikshospitalet HF University of Oslo Tine BA. Opplysningskontoret for meieriprodukter. The Research Council of Norway |
|---|---|
| Information provided by: | Rikshospitalet HF |
| ClinicalTrials.gov Identifier: | NCT00140816 |
Purpose
Foods containing more dairy fat (and thus a higher proportion of short and medium chain fatty acids and possibly some other nutrients or micronutrients with effect on energy intake, satiety or energy metabolism) affect energy balance and metabolic profile in subjects prone to develop abdominal adiposity and metabolic syndrome. The aim of the study is to test the hypothesis that intake of dairy products has a favorable effect on markers of the metabolic syndrome.
To explore such a hypothesis the participants have to be in a free living situation during an extended study period.
| Condition | Intervention |
|---|---|
|
Metabolic Syndrome X Heart Disease |
Behavioral: Increased intake of dairy products |
| Study Type: | Interventional |
| Study Design: | Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Dairy Products and Metabolic Effects - A Multicentre Nordic Study |
| Estimated Enrollment: | 40 |
| Study Start Date: | September 2005 |
| Study Completion Date: | November 2008 |
| Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 30 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Apparently healthy men and women aged 30-65 years with:
Traits of the metabolic syndrome - two or more of the following criteria fulfilled:
Exclusion Criteria:
Patients with any of the following conditions will not be included in the trial:
Concomitant medications:
Associated diseases or conditions:
Contacts and Locations| Norway | |
| Lipidklinikken, Medisinsk avdeling, Rikshospitalet | |
| Oslo, Norway, 0027 | |
| Principal Investigator: | Jan I Pedersen, Prof. dr. med. | Inst. of Basic Medical Sciences, Dept. of Nutrition, University of Oslo |
More Information
| Study ID Numbers: | Melk61015 |
| Study First Received: | August 30, 2005 |
| Last Updated: | February 12, 2009 |
| ClinicalTrials.gov Identifier: | NCT00140816 History of Changes |
| Health Authority: | Norway: The National Committees for Research Ethics in Norway |
|
Hyperinsulinism Metabolic Diseases Metabolic Syndrome X Heart Diseases |
Insulin Resistance Glucose Metabolism Disorders Metabolic Disorder Abdominal Obesity Metabolic Syndrome |
|
Hyperinsulinism Metabolic Diseases Pathologic Processes Disease Metabolic Syndrome X |
Heart Diseases Syndrome Cardiovascular Diseases Insulin Resistance Glucose Metabolism Disorders |